Almac and Illumina partner on next-gen in vitro assays

By Fiona BARRY

- Last updated on GMT

Almac Diagnostics is part of Almac Group
Almac Diagnostics is part of Almac Group

Related tags Partnership

Northern Ireland CDMO Almac is working with US gene testing company Illumina to create next-generation sequencing diagnostic assays.

The collaboration will use Illumina’s MiSeqDx tool, the first in vitro diagnostic next-generation sequencing (NGS) system to be approved by the FDA for clinical lab use. Almac Diagnostics, a daughter company of Almac Group, will contribute experience in developing multiplex RNA- and DNA-based tests from its current companion diagnostic partnerships with big pharma.

Almac said the partnership will allow it to offer a greater range of complex assays to its customers.

We are extremely pleased to announce this collaboration with Illumina​,” said Almac Diagnostics president and managing director Paul Harkin. “We are fully committed to the development of precision medicine and partnerships of this nature provide more avenues for test delivery, enabling development of diagnostic tests which will ultimately improve care in a wide range of disease areas.​”

Almac announced this week it is expanding its contract development footprint​ to Loughborough, England and hiring 180 people to run labs at AstraZeneca’s old process development site.

Related news

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us

Webinars

Headlines